Näytetään tulokset 1 - 10 / 46
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma

Vertaisarvioitu
DOI
10.1007/s12032-010-9592-2
Hernberg, Micaela ; Kivioja, Aarne H; Böhling, Tom; Wiklund, Tom Anders; Janes, Rita Jacqueline
Medical oncology2011

Factors affecting aggressive oral tongue cancer invasion and development of in vitro models for chemoradiotherapy assay

Avoin saatavuus
Väyrynen, Otto
Acta Universitatis Ouluensis. Series D, Medica2019

Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00405-015-3857-5
Niemensivu, Riina; Saarilahti, Kauko ; Ylikoski, Jukka; Aarnisalo, Antti; Mäkitie, Antti A.
European archives of oto-rhino-laryngology2016

Enteral tube feeding of head and neck cancer patients undergoing definitive chemoradiotherapy in the Nordic Countries:Survey of the Scandinavian Society for Head and Neck Oncology

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00405-020-06545-z
Ilmarinen, Taru; Hammarstedt-Nordenvall, Lalle; Bäck, Leif; Mäkitie, Antti
European archives of oto-rhino-laryngology2021

WRAP53 beta, survivin and p16(INK4a) expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.3892/or.2017.5898
Tiefenbock-Hansson, Katharina; Haapaniemi, Aaro; Farnebo, Lovisa; Palmgren, Bjorn; Tarkkanen, Jussi;...
Oncology reports2017

Treatment of the neck in residual/recurrent disease after chemoradiotherapy for advanced primary laryngeal cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.ejso.2024.108389
Rodrigo, Juan P.; López-Álvarez, Fernando; Medina, Jesús E.; Silver, Carl E.; Robbins, K. Thomas; Ha...
Ejso2024

Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1371/journal.pone.0285786
Holopainen, Erikka; Lahtinen, Olli; Könönen, Mervi; Anttila, Maarit; Vanninen, Ritva; Lindgren, Auni
PLoS ONE2023

Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer

Vertaisarvioitu
Holopainen E; Lahtinen O; Könönen M; Anttila M; Vanninen R; Lindgren A
Plos One2023

Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab

Vertaisarvioitu
Avoin saatavuus
DOI
10.3389/fonc.2025.1681420
Horndalsveen, Henrik; Haakensen, Vilde Drageset; Madebo, Tesfaye; Grønberg, Bjørn Henning; Halvorsen...
Frontiers in oncology2025

Changes in the use of chemoradiotherapy for non-small cell lung cancer after guideline implementation in Finland between 2016 and 2020

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.ctarc.2025.100996
Wichmann, Viktor; Skyttä, Tanja; Mali, Pekka; Anttonen, Anu; Lehtiö, Kaisa; Tengström, Maria; Nevant...
Cancer treatment and research communications2025

Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma

Vertaisarvioitu
DOI
10.1007/s12032-010-9592-2
2011

Factors affecting aggressive oral tongue cancer invasion and development of in vitro models for chemoradiotherapy assay

Avoin saatavuus
2019

Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00405-015-3857-5
2016

Enteral tube feeding of head and neck cancer patients undergoing definitive chemoradiotherapy in the Nordic Countries:Survey of the Scandinavian Society for Head and Neck Oncology

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00405-020-06545-z
2021

WRAP53 beta, survivin and p16(INK4a) expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.3892/or.2017.5898
2017

Treatment of the neck in residual/recurrent disease after chemoradiotherapy for advanced primary laryngeal cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.ejso.2024.108389
2024

Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1371/journal.pone.0285786
2023

Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer

Vertaisarvioitu
2023

Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab

Vertaisarvioitu
Avoin saatavuus
DOI
10.3389/fonc.2025.1681420
2025

Changes in the use of chemoradiotherapy for non-small cell lung cancer after guideline implementation in Finland between 2016 and 2020

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.ctarc.2025.100996
2025